BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 28593446)

  • 1. C3 glomerulonephritis with a severe crescentic phenotype.
    Ravindran A; Fervenza FC; Smith RJH; Sethi S
    Pediatr Nephrol; 2017 Sep; 32(9):1625-1633. PubMed ID: 28593446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
    Viswanathan GK; Nada R; Kumar A; Ramachandran R; Rayat CS; Jha V; Sakhuja V; Joshi K
    Diagn Pathol; 2015 Mar; 10():6. PubMed ID: 25889427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3 glomerulopathy and current dilemmas.
    Ito N; Ohashi R; Nagata M
    Clin Exp Nephrol; 2017 Aug; 21(4):541-551. PubMed ID: 27878657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
    Okuda Y; Ishikura K; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Fukuzawa R; Ogata K; Honda M
    Nephrology (Carlton); 2015 Apr; 20(4):286-92. PubMed ID: 25524631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
    Bomback AS; Santoriello D; Avasare RS; Regunathan-Shenk R; Canetta PA; Ahn W; Radhakrishnan J; Marasa M; Rosenstiel PE; Herlitz LC; Markowitz GS; D'Agati VD; Appel GB
    Kidney Int; 2018 Apr; 93(4):977-985. PubMed ID: 29310824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features of C3 glomerulopathy in children: a single-center experience.
    Drake KA; Ellington N; Gattineni J; Torrealba JR; Hendricks AR
    Pediatr Nephrol; 2020 Jan; 35(1):153-162. PubMed ID: 31667615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3 glomerulopathy.
    Servais A; Noël LH; Frémeaux-Bacchi V; Lesavre P
    Contrib Nephrol; 2013; 181():185-93. PubMed ID: 23689580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the complement biomarker profile of C3 glomerulopathy.
    Zhang Y; Nester CM; Martin B; Skjoedt MO; Meyer NC; Shao D; Borsa N; Palarasah Y; Smith RJ
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1876-82. PubMed ID: 25341722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C3 glomerulopathy: clinicopathologic features and predictors of outcome.
    Medjeral-Thomas NR; O'Shaughnessy MM; O'Regan JA; Traynor C; Flanagan M; Wong L; Teoh CW; Awan A; Waldron M; Cairns T; O'Kelly P; Dorman AM; Pickering MC; Conlon PJ; Cook HT
    Clin J Am Soc Nephrol; 2014 Jan; 9(1):46-53. PubMed ID: 24178974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy.
    Kersnik Levart T; Ferluga D; Vizjak A; Mraz J; Kojc N
    Diagn Pathol; 2016 Oct; 11(1):94. PubMed ID: 27717365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.
    Sethi S; Fervenza FC; Zhang Y; Zand L; Vrana JA; Nasr SH; Theis JD; Dogan A; Smith RJ
    Kidney Int; 2012 Aug; 82(4):465-73. PubMed ID: 22673887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E is enriched in dense deposits and is a marker for dense deposit disease in C3 glomerulopathy.
    Madden B; Singh RD; Haas M; Palma LMP; Sharma A; Vargas MJ; Gross L; Negron V; Nate T; Charlesworth MC; Theis JD; Nasr SH; Nath KA; Fervenza FC; Sethi S
    Kidney Int; 2024 May; 105(5):1077-1087. PubMed ID: 38447879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a Histologic Scoring Index for C3 Glomerulopathy.
    Caravaca-Fontán F; Trujillo H; Alonso M; Díaz-Encarnación M; Cabello V; Ariceta G; Quintana LF; Marco H; Barros X; Ramos N; Rodríguez-Mendiola N; Cruz S; Fernández-Juárez G; Rodríguez E; de la Cerda F; Pérez de José A; López I; Fernández L; Pérez Gómez V; Ávila A; Bravo L; Lumbreras J; Allende N; Sanchez de la Nieta MD; Olea T; Melgosa M; Huerta A; Miquel R; Mon C; Fraga G; de Lorenzo A; Draibe J; González F; Shabaka A; Illescas ML; Calvo C; Oviedo V; Da Silva I; Goicoechea de Jorge E; Caravaca F; Praga M;
    Am J Kidney Dis; 2021 May; 77(5):684-695.e1. PubMed ID: 33359150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney Transplantation in C3 Glomerulopathy: A Case Series.
    Regunathan-Shenk R; Avasare RS; Ahn W; Canetta PA; Cohen DJ; Appel GB; Bomback AS
    Am J Kidney Dis; 2019 Mar; 73(3):316-323. PubMed ID: 30413277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C3 Glomerulopathy and post-infectious glomerulonephritis define a disease spectrum.
    Al-Ghaithi B; Chanchlani R; Riedl M; Thorner P; Licht C
    Pediatr Nephrol; 2016 Nov; 31(11):2079-86. PubMed ID: 27008643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C3 glomerulonephritis and autoimmune disease: more than a fortuitous association?
    Alexander MP; Fervenza FC; De Vriese AS; Smith RJH; Nasr SH; Cornell LD; Herrera Hernandez LP; Zhang Y; Sethi S
    J Nephrol; 2016 Apr; 29(2):203-209. PubMed ID: 26187133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3 glomerulopathy associated with monoclonal Ig is a distinct subtype.
    Ravindran A; Fervenza FC; Smith RJH; Sethi S
    Kidney Int; 2018 Jul; 94(1):178-186. PubMed ID: 29729982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C3 glomerulonephritis associated with ANCA positivity: a case report.
    Li L; Liu LQ; Yang YY; Hu ZX
    BMC Nephrol; 2021 Apr; 22(1):143. PubMed ID: 33882866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of C3 in C3 glomerulopathy.
    Sethi S; Vrana JA; Fervenza FC; Theis JD; Sethi A; Kurtin PJ; Zhang Y; Smith RJH
    Nephrol Dial Transplant; 2017 Mar; 32(3):459-465. PubMed ID: 27507892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis.
    Xiao X; Pickering MC; Smith RJ
    Semin Thromb Hemost; 2014 Jun; 40(4):465-71. PubMed ID: 24799308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.